Ignite Creation Date:
2024-05-06 @ 9:13 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02935907
Status:
COMPLETED
Last Update Posted:
2022-07-12
First Post:
2016-10-13
Brief Title:
APG-115 in Patients With Advanced Solid Tumors or Lymphomas
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Organization Data
Organization:
Ascentage Pharma Group Inc
Class:
INDUSTRY
Study ID:
APG-115-US-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascentage Pharma Group Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None